Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (5y) (2022 - 2026)
Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.52 Bn | 35.79 Bn | 1.97 Bn |
| 2 | Zoetis | 33.53 Bn | 31.59 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.92 Bn | 21.77 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.96 Bn | 16.88 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.47 Bn | 15.15 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.76 Bn | 11.33 Bn | 785.00 Mn |
| 7 | Alkermes | 7.11 Bn | 6.60 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.53 Bn | 6.03 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 5.98 Bn | 5.23 Bn | 396.79 Mn |
| 10 | Liquidia | 5.44 Bn | 5.22 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.73% |
| Dec 31, 2025 | 3.19% |
| Sep 30, 2025 | -2.97% |
| Jun 30, 2025 | -5.49% |
| Mar 31, 2025 | -4.42% |
| Dec 31, 2024 | -14.02% |
| Sep 30, 2024 | 3.65% |
| Jun 30, 2024 | -16.13% |
| Mar 31, 2024 | -11.94% |
| Dec 31, 2023 | 32.39% |
| Sep 30, 2023 | -11.92% |
| Jun 30, 2023 | -5.75% |
| Mar 31, 2023 | -29.50% |
| Dec 31, 2022 | -38.52% |
| Sep 30, 2022 | 7.17% |
| Jun 30, 2022 | 32.48% |
| Mar 31, 2022 | -36.14% |